https://stock.noler.com/us/stock/raptor-pharmaceutical-corp https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/accounts-payable https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/accounts-receivable-net https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/accrued-bonuses-current https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/accrued-employee-benefits-current-and-noncurrent https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/accrued-liabilities-current https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/accrued-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/accrued-marketing-costs-current https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/accrued-professional-fees-current https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/accrued-professional-fees-current-and-noncurrent https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/accrued-royalties-current https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/accrued-salaries-current https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/accumulated-depreciation https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/acquired-indefinite-lived-intangible-assets https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/acquired-intangibles https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/acquired-net https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/acquisition-contingent-consideration-arrangements-change-in-amount-of-contingent-consideration-liability https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/acquisition-contingent-consideration-liability-noncurrent https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/acquisition-recognized-identifiable-assets-acquired-goodwill-and-liabilities-assumed-net https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/acquisition-separately-recognized-transactions-expenses-and-losses-recognized https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/acquisition-separately-recognized-transactions-revenues-and-gains-recognized https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/acquisitions https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/additional-paid-in-capital https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/adjustment-for-amortization https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/advertising-expense https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/amended-reports-10-k https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/amended-reports-10-kt https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/amended-reports-10-q https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/amortization https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/amortization-of-acquired-intangible-assets https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/amortization-of-acquisition-costs https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/amortization-of-financing-costs-and-discounts https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/aoci https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/assets-fair-value-disclosure https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/business-acquisition-purchase-price-allocation-current-assets-cash-and-cash-equivalents https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/business-acquisition-purchase-price-allocation-current-assets-prepaid-expense-and-other-assets https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/business-acquisition-purchase-price-allocation-current-liabilities-accrued-liabilities https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/business-acquisition-purchase-price-allocation-goodwill-amount https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/business-development https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/capital-expenditures https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/capital-lease-obligations-current https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/capital-lease-obligations-incurred https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/capital-lease-obligations-noncurrent https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/capital-leased-assets-gross https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/capital-leases-future-minimum-payments-due https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/capital-leases-future-minimum-payments-due-current https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/capital-leases-future-minimum-payments-due-in-five-years https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/capital-leases-future-minimum-payments-due-in-four-years https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/capital-leases-future-minimum-payments-due-in-three-years https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/capital-leases-future-minimum-payments-due-in-two-years https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/capital-leases-future-minimum-payments-due-thereafter https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/capital-leases-lessee-balance-sheet-assets-by-major-class-accumulated-deprecation https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/capitalized-computer-software-gross https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/cash-acquired-from-acquisition https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/cash-and-equivalents https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/cash-cash-equivalents-and-short-term-investments https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/cash-flow-breakdown https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/class-of-warrant-or-right-exercise-price-of-warrants-or-rights-1 https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/common-stock-value https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/comprehensive-income https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/concept-stock-issued-tag-2 https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/contractual-obligation https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/contractual-obligation-due-after-fifth-year https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/contractual-obligation-due-in-fifth-year https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/contractual-obligation-due-in-fourth-year https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/contractual-obligation-due-in-next-twelve-months https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/contractual-obligation-due-in-second-year https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/contractual-obligation-due-in-third-year https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/convertible-debt-noncurrent https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/cost-of-goods-sold https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/cost-of-revenue https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/cost-of-services-amortization https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/cost-of-services-licenses-and-maintenance-agreements https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/cover-page-shares-outstanding https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/current-assets https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/current-liabilities https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/customer-refund-liability-current https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/debt-face-amount https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/debt-interest-rate-stated-percentage https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/debt-maturing-after-year-five https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/debt-maturing-in-next-twelve-months https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/debt-maturing-in-year-five https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/debt-maturing-in-year-four https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/debt-maturing-in-year-three https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/debt-maturing-in-year-two https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/debt-maturing-remainder-of-fiscal-year https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/debt-related-commitment-fees-and-debt-issuance-costs https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/deferred-costs https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/deferred-finance-costs-noncurrent-net https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/deferred-finance-costs-ownshare-lending-arrangement-issuance-costs-accumulated-amortization-adjustment https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/deferred-rent-credit-current https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/deferred-revenue https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/deferred-revenue-revenue-recognized https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/deferred-tax-assets-gross https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/deferred-tax-assets-inventory https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/deferred-tax-assets-net https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/deferred-tax-assets-other https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/deferred-tax-liabilities https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/deferred-tax-liabilities-deferred-expense-capitalized-research-and-development-costs https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/deferred-tax-liabilities-noncurrent https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/defined-contribution-plan-cost-recognized https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/defined-contribution-plan-maximum-annual-contributions-per-employee-amount https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/deposits-assets-noncurrent https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/depreciation https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/development-stage-enterprise-deficit-accumulated-during-development-stage https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/dilutive-shares https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/effective-tax-rate https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/employee-related-liabilities-current https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/employee-stock-ownership-plan-esop-number-of-committed-to-be-released-shares https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/fair-value-concentration-of-risk-cash-and-cash-equivalents https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/fair-value-measurement-with-unobservable-inputs-reconciliations-recurring-basis-liability-value https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/federal-income-tax-expense-benefit https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/financing-cash-flow https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/finite-lived-intangible-assets-amortization-expense-next-twelve-months https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/finite-lived-intangible-assets-amortization-expense-remainder-of-fiscal-year https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/finite-lived-intangible-assets-amortization-expense-year-five https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/finite-lived-intangible-assets-amortization-expense-year-four https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/finite-lived-intangible-assets-amortization-expense-year-three https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/foreign-currency-transaction-gain-loss-before-tax https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/foreign-pretax-income https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/form-d-other https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/furniture-and-fixtures-gross https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/general-and-administrative-expense https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/goodwill https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/goodwill-acquired https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/goodwill-impaired-accumulated-impairment-loss https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/gross-profit https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/impairment-of-intangible-assets-excluding-goodwill https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/impairment-of-intangible-assets-indefinitelived-excluding-goodwill https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/impairment-of-long-lived-assets-held-for-use https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/income-tax https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/income-tax-credits-and-adjustments https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/income-tax-expense-benefit https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/income-taxes-paid https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/increase-decrease-in-deposit-other-assets https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/increase-decrease-in-intangible-assets-current https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/increase-decrease-in-inventories https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/increase-decrease-in-other-receivables https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/increase-decrease-in-restricted-cash https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/incremental-common-shares-attributable-to-call-options-and-warrants https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/incremental-common-shares-attributable-to-share-based-payment-arrangements https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/insider-transactions-other https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/insider-transactions-stock-options https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/insider-transactions-stock-units https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/insider-transactions-warrants https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/intangible-assets-gross-excluding-goodwill https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/interest-and-debt-expense https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/interest-expense https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/interest-paid https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/interest-payable-current https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/inventory https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/inventory-finished-goods https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/inventory-raw-materials https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/inventory-valuation-reserves https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/inventory-work-in-process https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/investing-cash-flow https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/investment-income-interest https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/lease-and-rental-expense https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/leasehold-improvements-gross https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/level-3-liability-gain-loss-included-in-earnings https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/level-3-liability-settlements https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/liabilities-fair-value-disclosure https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/liability-for-uncertain-tax-positions-current https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/line-of-credit https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/line-of-credit-facility-remaining-borrowing-capacity https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/long-term-notes-payable https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/machinery-and-equipment-gross https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/marketable-securities-realized-gain-loss-excluding-other-than-temporary-impairments https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/net-cash-from-financing-activities https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/net-cash-from-investing-activities https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/net-cash-from-operating-activities https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/net-change-in-cash https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/net-income https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/notes-issued https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/notes-payable-current https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/number-of-operating-segments https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/number-of-reportable-segments https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax-change https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/oci-foreign-currency-transaction-and-translation-gain-loss-arising-net-of-tax https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/oci-net-of-tax https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/operating-cash-flow https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/operating-expenses https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/operating-income https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/operating-lease-payments-due https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/operating-lease-payments-due-current https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/other-accrued-liabilities-current https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/other-commitment https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/other-commitment-due-after-fifth-year https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/other-commitment-due-in-fifth-year https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/other-commitment-due-in-fourth-year https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/other-commitment-due-in-next-twelve-months https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/other-commitment-due-in-second-year https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/other-commitment-due-in-third-year https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/other-inventory https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/other-noncurrent-assets https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/other-nonoperating-income https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/other-prepaid-expense-current https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/other-short-term-investments https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/payment-of-financing-and-stock-issuance-costs https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/payments-of-financing-costs https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/payments-to-acquire-assets-investing-activities https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/payments-to-acquire-investments https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/payments-to-acquire-productive-assets https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/payments-to-acquire-short-term-investments https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/preferred-shares-facts https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/preferred-stock-shares-authorized https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/preferred-stock-shares-issued https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/preferred-stock-value https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/pretax-income https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/pretax-income-domestic https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/proceeds-from-issuance-of-debt https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/proceeds-from-issuance-of-private-placement https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/proceeds-from-issuance-of-shares-under-incentive-and-share-based-compensation-plans-including-stock-options https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/proceeds-from-loan-originations https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/proceeds-from-notes-payable https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/proceeds-from-sale-maturity-and-collections-of-investments https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/proceeds-from-sale-of-short-term-investments https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/proceeds-from-short-term-capital-lease-obligations https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/proceeds-from-stock-issued https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/property-plant-and-equipment-gross https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/property-plant-equipment https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/public-float https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/realized-gain-loss-on-marketable-securities-cost-method-investments-and-other-investments https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/recognition-of-deferred-revenue https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/repayments-of-debt https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/repayments-of-debt-and-capital-lease-obligations https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/repayments-of-long-term-capital-lease-obligations https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/repayments-of-notes-payable https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/research-and-development https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/restricted-cash-and-cash-equivalents https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/restricted-cash-and-cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/retained-earnings https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/revenue https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/revenue-recognition-sales-returns-reserve-for-sales-returns https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/sale-of-stock-price-per-share https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/sales-returns-goods https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/sales-revenue-goods-net https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/sales-revenue-net https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/sec-comment-letters-corresp https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/sec-comment-letters-upload https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/sec-filings-10-k https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/sec-filings-10-kt https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/sec-filings-10-q https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/sec-filings-10ksb https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/sec-filings-10qsb https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/sec-filings-10sb12g https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/sec-filings-15-12g https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/sec-filings-25-nse https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/sec-filings-425 https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/sec-filings-8-a12g https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/sec-filings-8-k https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/sec-filings-ars https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/sec-filings-ct-order https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/sec-filings-def-14a https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/sec-filings-defa14a https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/sec-filings-defr14a https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/sec-filings-pre-14a https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/sec-filings-regdex https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/sec-filings-s-4 https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/sec-filings-sb-2 https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/sec-filings-sc-14d9 https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/sec-filings-sc-to-c https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/sec-filings-sc-to-t https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/sec-filings-sc14d9c https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/secondary-offerings-form-424b3 https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/secondary-offerings-form-424b5 https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/secondary-offerings-form-effect https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/secondary-offerings-form-pos-am https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/secondary-offerings-form-posasr https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/secondary-offerings-form-rw https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/secondary-offerings-form-s-1 https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/secondary-offerings-form-s-3 https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/secondary-offerings-form-s-3asr https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/secondary-offerings-form-s-8-pos https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/sga-expense https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-exercisable-options-average-exercise-price https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-number-of-exercisable-options https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-number-of-outstanding-options https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-outstanding-options-average-exercise-price-beginning-balance https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/share-based-goods-and-nonemployee-services-transaction-expense https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/shareholders-equity https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/shares-authorized https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/shares-issued https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/shares-issued-2 https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/short-term-investments https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/stock-award-fair-value-assumptions-expected-volatility-rate-maximum https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/stock-award-fair-value-assumptions-expected-volatility-rate-minimum https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/stock-award-fair-value-assumptions-risk-free-interest-rate-maximum https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/stock-award-fair-value-assumptions-risk-free-interest-rate-minimum https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/stock-award-number-of-additional-shares-authorized https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/stock-award-number-of-shares-authorized https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/stock-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/stock-award-plan-modification-incremental-compensation-cost https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/stock-award-purchase-price-of-common-stock-percent https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/stock-award-rsu-vested-in-period-total-fair-value https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/stock-based-compensation https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/stock-issued-new-shares-sold https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/stock-issued-shares-issued-value-espp https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/stock-issued-shares-issued-value-issued-for-cash https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/stock-issued-shares-issued-value-other https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/stock-issued-shares-issued-value-purchase-of-assets https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/stock-issued-shares-issued-value-restricted-stock-award-net-of-forfeitures https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/stock-issued-value-of-shares-issued-for-acquisitions https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/stock-issued-value-of-shares-issued-for-stock-awards https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/stock-options-exercisable-number https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/stock-options-forfeitures-and-expirations-in-period https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/stock-options-forfeitures-and-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/stock-options-outstanding-number https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/stock-options-vested-and-expected-to-vest-outstanding-aggregate-intrinsic-value https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/stock-repurchase-program-number-of-shares-authorized-to-be-repurchased https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/tax-rate-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/tax-rate-reconciliation-tax-credits-research https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/tax-reconciliation-nondeductible-expense-other https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/tax-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/tax-reconciliation-tax-credits-research https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/total-assets https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/total-liabilities https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/total-liabilities-and-equity https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/total-long-term-debt https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/unrealized-gain-loss-on-investments https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/unrealized-gain-loss-on-marketable-securities-cost-method-investments-and-other-investments https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/unrecognized-tax-benefits https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/us-government-securities-at-carrying-value https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/utb-income-tax-penalties-and-interest-accrued https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/warrants-and-rights-outstanding https://stock.noler.com/us/stock/raptor-pharmaceutical-corp/weighted-average-number-of-share-outstanding-basic-and-diluted